Log In
BCIQ
Print this Print this
 

APL-NPC-201

  Manage Alerts
Collapse Summary General Information
Company Aten Porus Lifesciences
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard IndicationGlycosphingolipid storage disorders
Indication DetailsTreat Niemann-Pick disease type C (NPC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today